Alzheimer's disease: pathogenesis, diagnostics, and therapeutics
Currently, 47 million people live with dementia globally, and it is estimated to increase more
than threefold (~ 131 million) by 2050. Alzheimer's disease (AD) is one of the major …
than threefold (~ 131 million) by 2050. Alzheimer's disease (AD) is one of the major …
Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology
KE Sapsford, WR Algar, L Berti, KB Gemmill… - Chemical …, 2013 - ACS Publications
Bionanotechnology has now become firmly established in its own right as one of the
principle and focused subdisciplines within nanotechnology.(1-10) Bionanotechnology can …
principle and focused subdisciplines within nanotechnology.(1-10) Bionanotechnology can …
Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers
N Poovaiah, Z Davoudi, H Peng, B Schlichtmann… - Nanoscale, 2018 - pubs.rsc.org
Neurodegenerative diseases refer to disorders of the central nervous system (CNS) that are
caused by neuronal degradations, dysfunctions, or death. Alzheimer's disease, Parkinson's …
caused by neuronal degradations, dysfunctions, or death. Alzheimer's disease, Parkinson's …
Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology
Current biomedical imaging techniques including magnetic resonance imaging (MRI),
positron emission tomography (PET), and computed X-ray tomography (CT) are vital in the …
positron emission tomography (PET), and computed X-ray tomography (CT) are vital in the …
Inhibition of amyloid β protein fibrillation by polymeric nanoparticles
C Cabaleiro-Lago, F Quinlan-Pluck… - Journal of the …, 2008 - ACS Publications
Copolymeric NiPAM: BAM nanoparticles of varying hydrophobicity were found to retard
fibrillation of the Alzheimer's disease-associated amyloid β protein (Aβ). We found that these …
fibrillation of the Alzheimer's disease-associated amyloid β protein (Aβ). We found that these …
Recent advancements of nanomedicine in neurodegenerative disorders theranostics
S Mukherjee, VS Madamsetty… - Advanced Functional …, 2020 - Wiley Online Library
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Alzheimer's disease (AD) represents the most common form of dementia worldwide,
affecting more than 35 million people. Advances in nanotechnology are beginning to exert a …
affecting more than 35 million people. Advances in nanotechnology are beginning to exert a …
[HTML][HTML] Cerium dioxide nanoparticles synthesized via precipitation at constant pH: Synthesis, physical-chemical and antioxidant properties
Y Shlapa, S Solopan, V Sarnatskaya… - Colloids and Surfaces B …, 2022 - Elsevier
Abstract Cerium oxide nanoparticles (CeO 2 NPs) are well known for their application in
various fields of industry, as well as in biology and medicine. Knowledge of synthesis …
various fields of industry, as well as in biology and medicine. Knowledge of synthesis …
Advances on therapeutic strategies for Alzheimer's disease: from medicinal plant to nanotechnology
NA Hassan, AK Alshamari, AA Hassan, MG Elharrif… - Molecules, 2022 - mdpi.com
Alzheimer's disease (AD) is a chronic dysfunction of neurons in the brain leading to
dementia. It is characterized by gradual mental failure, abnormal cognitive functioning …
dementia. It is characterized by gradual mental failure, abnormal cognitive functioning …
[HTML][HTML] Neurotheranostics as personalized medicines
The discipline of neurotheranostics was forged to improve diagnostic and therapeutic
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …